Poland· PL-100110300
Quadramet
A samarium (153sm) lexidronam product containing samarium [153 sm] lexidronam pentasodium, registered in Poland by CIS bio international. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Samarium (153sm) lexidronam is registered in 8 of 19 countries.
Countries holding a registration under ATC V10BX02 (samarium (153sm) lexidronam), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Samarium (153sm) lexidronam · ATC V10BX02
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- samarium [153 Sm] lexidronam pentasodium
- Manufacturer
- CIS bio international
- Country
- Poland (PL)
- ATC code
- V10BX02
- ATC class
- Samarium (153Sm) lexidronam
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990942015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V10BX02
Samarium (153sm) lexidronam, as other registers publish it.
- DenmarkQuadrametCis Bio International
- FinlandQuadrametCIS bio international
- IcelandQuadrametCis bio international*
- CzechiaQUADRAMETCIS bio international, Gif-sur-Yvette Cedex
- BelgiumQuadramet 1.3 GBq/mlCis Bio International
- IrelandQuadramet 1.3 GBq/mL solution for injection.CIS bio International
- NetherlandsQUADRAMET, oplossing voor injectie 1,3 GBq/mlCis Bio International
- FinlandSamarium (153 Sm)-EdtmpMAP Medical Technologies Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2e96ba5-fc87-4ff4-956f-10ebd7ab274b GET /v1/drugs/a2e96ba5-fc87-4ff4-956f-10ebd7ab274b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "1,3 GBq/ml w dniu odniesienia (co odpowiada 20-80 mcg/ml samaru na fiolkę)",
"packaging": "05909990942015 ¦ Rpz ¦ EU/1/97/057/001 ¦ 18824\n1 fiol.",
"substance": null,
"common_name": "samarium [153 Sm] lexidronam pentasodium",
"pl_product_id": "100110300",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about samarium (153sm) lexidronam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.